GlassScriptPhysician profile
Syed Nasir
NPI 1376697045
$934.58
in general payments reported to CMS, 2019-2025
15 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.46 · 2020: $230 · 2021: $152 · 2023: $76.03 · 2024: $116 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $317.44 | 2024-2025 | Intellis Adaptivestim, Inceptiv, V-Loc 180 |
| Teva Pharmaceuticals USA, INC. | $263.22 | 2020-2024 | Austedo Xr, Ajovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.78 | 2020-2024 | Relistor |
| Redhill Biopharma INC. | $56.33 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $46.02 | 2019-2021 | |
| Boston Scientific Corporation | $32.56 | 2023 | |
| Depuy Synthes Sales INC. | $30.95 | 2021-2025 | Orthovisc, Monovisc |
| Globus Medical, INC. | $30.93 | 2025 | Senza |
| Pfizer INC. | $19.49 | 2024 | |
| Nalu Medical, INC. | $17.93 | 2021 | |
| Zimmer Biomet Holdings, INC. | $15.18 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Ibsa Pharma INC. | $14.41 | 2021 | |
| Collegium Pharmaceutical, INC. | $13.26 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $13.08 | 2024 | Kristalose |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Nasir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.